The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
29 4月 2025現在、最大の保有資産はEli Lilly Co. COM NPV, UnitedHealth Group Inc. COM USD0.01, AstraZeneca PLC ORD USD0.25, Johnson Johnson COM USD1.00, Boston Scientific Corporation COM USD0.01, Abbott Laboratories COM NPVを含みます。JFNNX ファンドの保有資産の完全なリストを確認してください。
JFNNX ファンドの保有資産は何ですか?
JFNNX ファンドは8の保有資産で構成されており、Eli Lilly Co. COM NPV, UnitedHealth Group Inc. COM USD0.01, AstraZeneca PLC ORD USD0.25などが含まれます。JFNNX ファンドの保有資産の完全なリストを確認してください。